Comparison of Detection Sensitivity for Human Papillomavirus between Self-collected Vaginal Swabs and Physician-collected Cervical Swabs by Electrochemical DNA Chip

  • Nilyanimit, Pornjarim (Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University) ;
  • Wanlapakorn, Nasamon (Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University) ;
  • Niruthisard, Somchai (Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University) ;
  • Takahashi, Masayoshi (Toshiba Corporation) ;
  • Vongpunsawad, Sompong (Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University) ;
  • Poovorawan, Yong (Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University)
  • Published : 2015.01.22


Background: Human papillomavirus (HPV) DNA testing is an effective method to screen for precancerous changes in the cervix. Samples from self-collection rather than Pap smear can potentially be used to test for HPV as they are more acceptable and preferred for use in certain settings. The objective of this study was to compare HPV DNA testing from self-collected vaginal swabs and physician-collected cervical swabs. Materials and Methods: A total of 101 self-collected vaginal and physician-collected cervical swabs of known cytology from Thai women were tested by electrochemical DNA chip assay. The specimens were divided into 4 groups: 29 with normal cytology, 14 with atypical squamous cells of undetermined significance (ASCUS), 48 with low-grade squamous intraepithelial lesion (LSIL), and 10 with high-grade squamous intraepithelial lesion (HSIL). Results: Positive detection rates of HPV from self-collected swabs were similar to those from physician-collected swabs. Among specimens with abnormal cytology, HPV was found in 50% of self-collected swabs and 47.2% of physician-collected swabs. In specimens with normal cytology, 17.2% of self-collected swabs and 24.1% of physician-collected swabs were positive for HPV. Concordance was relatively high between results from self-collected and physician-collected samples. The most common HPV genotype detected was HPV 51. Conclusions: HPV DNA testing using self-collected swabs is a feasible alternative to encourage and increase screening for cervical cancer in a population who might otherwise avoid this important preventive examination due to embarrassment, discomfort, and anxiety.


  1. Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, et al (2010). Prevalence and genotypes of human papillomavirus among Thai women. Asian Pac J Cancer Prev, 11, 117-22.
  2. Chansaenroj J, Theamboonlers A, Chinchai T, et al (2012). High-risk human papillomavirus genotype detection by electrochemical DNA chip method. Asian Pac J Cancer Prev, 13, 1151-8.
  3. De Antonio JC, Fernandez-Olmos A, Mercadillo M, et al (2008). Detection of high-risk human papillomavirus by two molecular techniques: hybrid capture and linear array. J Virol Methods, 149, 163-6.
  4. Garcia F, Barker B, Santos C, et al (2003). Cross-sectional study of patient-and physician-collected cervical cytology and human papillomavirus. Obstet Gynecol, 102, 266-72.
  5. Gravitt PE, Peyton CL, Alessi TQ, et al (2000). Improved amplification of genital human papillomaviruses. J Clin Microbiol, 38, 357-61.
  6. Hagiwara M, Sasaki H, Matsuo K, et al (2007). Loop-mediated isothermal amplification method for detection of human papillomavirus type 6, 11,16, and 18. J Med Virol, 79, 605-15.
  7. Harper DM, Noll WW, Belloni DR, et al (2002). Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed--biologic concordance and women's preferences. Am J Obstet Gynecol, 186, 365-73.
  8. Khan MJ, Castle PE, Lorincz AT, et al (2005). The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst, 97, 1072-9.
  9. Koutsky L (1997). Epidemiology of genital human papillomavirus infection. Am J Med, 102, 3-8.
  10. Munoz M, Camargo M, Soto-De Leon SC, et al (2013). Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples. PLoS One, 8, 56509.
  11. Adler DH, Laher F, Lazarus E, et al (2013). A Viable and simple self-sampling method for human papillomavirus detection among South African adolescents. J Immunol Tech Infect Dis, 2.
  12. Bissett SL, Howell-Jones R, Swift C, et al (2011). Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. J Med Virol, 83, 1744-51.
  13. Nilyanimit P, Wanlapakorn N, Niruthisard S, et al (2013). Detection of human papillomavirus in male and female urine by electrochemical DNA chip and PCR sequencing. Asian Pac J Cancer Prev, 14, 5519-25."
  14. Onuki M, Matsumoto K, Satoh T, et al (2009). Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer. Cancer Sci, 100, 1312-6.
  15. Oranratanaphan S, Termrungruanglert W, Khemapech N (2014). Acceptability of self-sampling HPV testing among Thai women for cervical cancer screening. Asian Pac J Cancer Prev, 15, 7437-41.
  16. Parkin DM, Bray FI, Devesa SS (2001). Cancer burden in the year 2000. The global picture. Eur J Cancer, 37, 4-66.
  17. Petignat P, Roy M (2007). Diagnosis and management of cervical cancer. BMJ, 335, 765-8.
  18. Rugpao S, Koonlertkit S, Ruengkrist T, et al (2009). ThinPrep Pap-smear and cervical intraepithelial neoplasia in reproductive-aged Thai women. J Obstet Gynaecol Res, 35, 551-4.
  19. Safaeian M, Solomon D, Castle PE (2007). Cervical cancer prevention--cervical screening: science in evolution. Obstet Gynecol Clin North Am, 34, 739-60
  20. Safaeian M, Kiddugavu M, Gravitt PE, et al (2007). Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sex Transm Dis, 34, 429-36.
  21. Scarinci IC, Litton AG, Garces-Palacio IC, et al (2013). Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta. Womens Health Issues, 23, 123-30.
  22. Sellors JW, Lorincz AT, Mahony JB, et al (2000). Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ, 163, 513-8.
  23. Solomon D, Davey D, Kurman R, et al (2002). Forum group members;bethesda 2001 workshop. the 2001 bethesda system: terminology for reporting results of cervical cytology. JAMA, 287, 2114-9.
  24. Sriamporn S, Khuhaprema T, Parkin M (2006). Cervical cancer screening in Thailand: an overview. J Med Screen, 13, 39-43.
  25. Wang JL, Yang YZ, Dong WW, et al (2013). Application of human papillomavirus in screening for cervical cancer and precancerous lesions. Asian Pac J Cancer Prev, 14, 2979-82.